Identification of an analgesic lipopeptide produced by the probiotic Escherichia coli strain Nissle 1917
Escherichia coli Nissle is a probiotic that decreases visceral pain associated with irritable bowel syndrome. Here, the authors show that the microbe produces an analgesic lipopeptide, structurally related to GABA, that can cross the gut epithelial barrier and inhibits visceral hypersensitivity in m...
Main Authors: | Teresa Pérez-Berezo, Julien Pujo, Patricia Martin, Pauline Le Faouder, Jean-Marie Galano, Alexandre Guy, Claude Knauf, Jean Claude Tabet, Sophie Tronnet, Frederick Barreau, Maud Heuillet, Gilles Dietrich, Justine Bertrand-Michel, Thierry Durand, Eric Oswald, Nicolas Cenac |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2017-11-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-017-01403-9 |
Similar Items
-
Probiyotik Escherichia coli Suşu Nissle 1917
by: Seda Altuntaş, et al.
Published: (2017-12-01) -
Probiyotik Escherichia coli Suşu Nissle 1917
by: Seda Altuntaş, et al.
Published: (2017-12-01) -
Probiyotik Escherichia coli Suşu Nissle 1917
by: Seda Altuntaş, et al.
Published: (2017-12-01) -
Probiyotik Escherichia coli Suşu Nissle 1917
by: Seda ALTUNTAŞ, et al.
Published: (2017-12-01) -
Oral Administration of the Probiotic Strain Escherichia coli Nissle 1917 Reduces Susceptibility to Neuroinflammation and Repairs Experimental Autoimmune Encephalomyelitis-Induced Intestinal Barrier Dysfunction
by: Thomas Secher, et al.
Published: (2017-09-01)